Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | 7,301 | reported | 13 Mar 2026 | tx 14+488,750−15,199 |
| Bioverativ Inc. | 0 | reported | 08 Mar 2018 | tx 28+319,979−202,707.2 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,750 | — | |
| 13 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 1,342 | 55.23 USD | |
| 12 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,750 | 0.00 USD | deriv |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 7,500 | — | |
| 10 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 2,607 | 60.11 USD | |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 7,500 | 0.00 USD | deriv |
| 09 Mar 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 7,500 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 15,000 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 80,000 | 0.00 USD | deriv |
| 12 Mar 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 15,000 | 0.00 USD | deriv |
| 12 Mar 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 80,000 | 0.00 USD | deriv |
| 11 Mar 2024 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 100,000 | 0.00 USD | deriv |
| 10 Mar 2023 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 45,000 | 0.00 USD | deriv |
| 07 Nov 2022 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 135,000 | 0.00 USD | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 30,600.2 | — | |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 59,595 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 29,797 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 29,797 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 31,818 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 7,489 | — | deriv |
| 23 Feb 2018 | TAX_WITHHOLDING | Bioverativ Inc. | 917 | 104.74 USD | |
| 22 Feb 2018 | TAX_WITHHOLDING | Bioverativ Inc. | 2,011 | 104.30 USD | |
| 14 Feb 2018 | EXERCISE | Bioverativ Inc. | 3,744 | 0.00 USD | |
| 14 Feb 2018 | TAX_WITHHOLDING | Bioverativ Inc. | 1,136 | 103.52 USD | |
| 14 Feb 2018 | EXERCISE | Bioverativ Inc. | 3,744 | 0.00 USD | deriv |